Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment

References

• Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci. 2013;48:416–427.
   PubMed Web of Science ®Google Scholar
• Foo J, Michor F. Evolution of acquired resistance to anti-cancer therapy. J Theor Biol. 2014;355:10–20.
   PubMed Web of Science ®Google Scholar
• Yang Z, Gao D, Cao Z, et al. Drug and gene co-delivery systems for cancer treatment. Biomater Sci UK. 2015;3:1035–1049.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3:133.
   PubMed Web of Science ®Google Scholar
• Patel T, Zhou J, Piepmeier JM, et al. Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev. 2012;64:701–705.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Ebrahimian M. Recent advances in nanoformulations for co-delivery of curcumin and chemotherapeutic drugs. Nanomedicine. 2017;4:1–7.
   Web of Science ®Google Scholar
• Davis ME, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771–782.
   PubMed Web of Science ®Google Scholar
• Kang L, Gao Z, Huang W, et al. Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment. Acta Pharmaceutica Sinica B. 2015;5:169–175.
   PubMed Web of Science ®Google Scholar
• Yang T, Li B, Qi S, et al. Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo. Theranostics. 2014;4:1096–1111.
   PubMed Web of Science ®Google Scholar
• Zhou X, Zheng Q, Wang C, et al. Star-shaped amphiphilic hyperbranched polyglycerol-conjugated with dendritic poly (L-lysine) for the co-delivery of docetaxel and MMP-9 siRNA in cancer therapy. ACS Appl Mater Interfaces. 2016;8:12609–12619.
   PubMed Web of Science ®Google Scholar
• Sheu MT, Jhan HJ, Su CY, et al. Codelivery of doxorubicin-containing thermosensitive hydrogels incorporated with docetaxel-loaded mixed micelles enhances local cancer therapy. Colloids Surf B Biointerfaces. 2016;143:260–270.
   PubMed Web of Science ®Google Scholar
• Liechty WB, Kryscio DR, Slaughter BV, et al. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2010;1:149–173.
   PubMed Web of Science ®Google Scholar
• Mokhtarzadeh A, Alibakhshi A, Yaghoobi H, et al. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers. Expert Opin Biol Ther. 2016;16:771–785.
   PubMed Web of Science ®Google Scholar
• Lee AL, Wang Y, Cheng HY, et al. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials. 2009;30:919–927.
   PubMed Web of Science ®Google Scholar
• Ke XY, Ng VWL, Gao SJ, et al. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials. 2014;35:1096–1108.
   PubMed Web of Science ®Google Scholar
• Carlson LJ, Cote B, Alani AW, et al. Polymeric micellar co‐delivery of resveratrol and curcumin to mitigate in vitro doxorubicin‐induced cardiotoxicity. J Pharm Sci. 2014;103:2315–2322.
   PubMed Web of Science ®Google Scholar
• Zhu C, Jung S, Luo S, et al. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA–PCL–PDMAEMA triblock copolymers. Biomaterials. 2010;31:2408–2416.
   PubMed Web of Science ®Google Scholar
• Tang S, Yin Q, Zhang Z, et al. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer. Biomaterials. 2014;35:6047–6059.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu B, Bai T, et al. Co-delivery of doxorubicin and tumor-suppressing p53 gene using a POSS-based star-shaped polymer for cancer therapy. Biomaterials. 2015;55:12–23.
   PubMed Web of Science ®Google Scholar
• Zhu L, Perche F, Wang T, et al. Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. Biomaterials. 2014;35:4213–4222.
   PubMed Web of Science ®Google Scholar
• Chen W, Yuan Y, Cheng D, et al. Co‐delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy. Small. 2014;10:2678–2687.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao C, Li M, et al. Co‐delivery of 10‐hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy. Macromol Biosci. 2013;13:584–594.
   PubMed Web of Science ®Google Scholar
• Cai L, Xu G, Shi C, et al. Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: a synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials. 2015;37:456–468.
   PubMed Web of Science ®Google Scholar
• Han L, Huang R, Li J, et al. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. Biomaterials. 2011;32:1242–1252.
   PubMed Web of Science ®Google Scholar
• Biswas S, Deshpande PP, Navarro G, et al. Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery. Biomaterials. 2013;34:1289–1301.
   PubMed Web of Science ®Google Scholar
• Ren Y, Kang CS, Yuan XB, et al. Co-delivery of as-miR-21 and 5-FU by poly (amidoamine) dendrimer attenuates human glioma cell growth in vitro. J Biomater Sci Polym Ed. 2010;21:303–314.
   PubMed Web of Science ®Google Scholar
• Han M, Lv Q, Tang XJ, et al. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex. J Control Release. 2012;163:136–144.
   PubMed Web of Science ®Google Scholar
• Liu T, Xue W, Ke B, et al. Star-shaped cyclodextrin-poly(l-lysine) derivative co-delivering docetaxel and MMP-9 siRNA plasmid in cancer therapy. Biomaterials. 2014;35:3865–3872.
   PubMed Web of Science ®Google Scholar
• Zhu H, Chen H, Zeng X, et al. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials. 2014;35:2391–2400.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao Y, Wu Y, et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials. 2011;32:8281–8290.
   PubMed Web of Science ®Google Scholar
• Tang X, Liang Y, Feng X, et al. Co-delivery of docetaxel and poloxamer 235 by PLGA–TPGS nanoparticles for breast cancer treatment. Mater Sci Eng C Mater Biol Appl. 2015;49:348–355.
   PubMed Web of Science ®Google Scholar
• Katiyar S, Muntimadugu SE, Rafeeqi TA, et al. Co-delivery of rapamycin-and piperine-loaded polymeric nanoparticles for breast cancer treatment. Drug Deliv. 2016;23:2608–2616.
   PubMed Web of Science ®Google Scholar
• Zhou L, Duan X, Zeng S, et al. Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis. Int J Nanomedicine. 2015;10:5205.
   PubMed Web of Science ®Google Scholar
• Ediriwickrema A, Zhou J, Deng Y, et al. Multi-layered nanoparticles for combination gene and drug delivery to tumors. Biomaterials. 2014;35:9343–9354.
   PubMed Web of Science ®Google Scholar
• Liu H, Li Y, Mozhi A, et al. SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment. Biomaterials. 2014;35:6519–6533.
   PubMed Web of Science ®Google Scholar
• Su WP, Cheng FY, Shieh DB, et al. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. Int J Nanomedicine. 2012;7:4269–4283.
   PubMed Web of Science ®Google Scholar
• Devulapally R, Sekar NM, Sekar TV, et al. Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy. ACS Nano. 2015;9:2290–2302.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang J, Wang Y, et al. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Nanomed Nanotechnol Biol Med. 2016;12:411–420.
   PubMed Web of Science ®Google Scholar
• EbrahimianTaghavi M, Mokhtarzadeh S, Ramezani A, et al. Co-delivery of doxorubicin encapsulated PLGA nanoparticles and Bcl-xL shRNA using alkyl-modified PEI into breast cancer cells. Biochem Biotechnol. 2017;183:126–136.
   PubMed Web of Science ®Google Scholar
• Farajzadeh R, Pilehvar-Soltanahmadi Y, Dadashpour M, et al. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. Artif Cells Nanomed Biotechnol. 2017; Forthcoming. [9 p.]. doi: 10.1080/21691401.2017.1347879.
   PubMed Web of Science ®Google Scholar
• Xiao B. Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. J Mater Chem B Mater Biol Med. 2015;3:7724–7733.
   PubMed Web of Science ®Google Scholar
• Jia M, Li Y, Yang X, et al. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect. ACS Appl Mater Interfaces. 2014;6:11413–11423.
   PubMed Web of Science ®Google Scholar
• Ma Y, Fan X, Li L. pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel. Carbohydrate Polymers. 2016;137:19–29.
   PubMed Web of Science ®Google Scholar
• Bao X, Wang W, Wang C, et al. A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy. Biomaterials. 2014;35:8450–8466.
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang SB, Chen AZ, et al. Codelivery of paclitaxel and small interfering RNA by octadecyl quaternized carboxymethyl chitosan-modified cationic liposome for combined cancer therapy. J Biomater Appl. 2015;30:351–360.
   PubMed Web of Science ®Google Scholar
• Deng X, Cao M, Zhang J, et al. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterials. 2014;35:4333–4344.
   PubMed Web of Science ®Google Scholar
• Yu X, Yang G, ShiY, et al. Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance. Int J Nanomedicine. 2015;10:7045–7056.
   PubMed Web of Science ®Google Scholar
• Shali H, Shabani M, Pourgholi F, et al. Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line. Artif Cells Nanomed Biotechnol. 2017; Forthcoming. [10 p.]. doi: 10.1080/21691401.2017.1307212.
   PubMed Web of Science ®Google Scholar
• Shi S, Zhu X, Guo Q, et al. Self-assembled mPEG-PCL-g-PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro. Int J Nanomedicine. 2012;7:1749–1759.
   PubMed Web of Science ®Google Scholar
• Guan X, Li Y, Jiao Z, et al. Codelivery of antitumor drug and gene by a pH-sensitive charge-conversion system. ACS Appl Mater Interfaces. 2015;7:3207–3215.
   PubMed Web of Science ®Google Scholar
• Huang HY, Kuo WT, Chou MJ, et al. Co‐delivery of anti‐vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. J Biomed Mater Res. 2011;97:330–338.
   Google Scholar
• Davoodi P, Srinivasan MP, Wang CH. Synthesis of intracellular reduction-sensitive amphiphilic polyethyleneimine and poly (ε-caprolactone) graft copolymer for on-demand release of doxorubicin and p53 plasmid DNA. Acta Biomaterialia. 2016;39:79–93.
   PubMed Web of Science ®Google Scholar
• Lv S, Tang Z, Li M, et al. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Biomaterials. 2014;35:6118–6129.
   PubMed Web of Science ®Google Scholar
• Kaneshiro TL, Lu ZR. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials. 2009;30:5660–5666.
   PubMed Web of Science ®Google Scholar
• Zheng C, Zheng M, Gong P, et al. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Biomaterials. 2013;34:3431–3438.
   PubMed Web of Science ®Google Scholar
• Ma D, Lin QM, Zhang LM, et al. A star-shaped porphyrin-arginine functionalized poly(L-lysine) copolymer for photo-enhanced drug and gene co-delivery. Biomaterials. 2014;35:4357–4367.
   PubMed Web of Science ®Google Scholar
• Xu W, Ling P, Zhang T. Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv. 2013;2013:340415.
   Google Scholar
• Soltani F, Parhiz H, Mokhtarzadeh A, et al. Synthetic and biological vesicular nano-carriers designed for gene delivery. Curr Pharm Des. 2015;21:6214–6235.
   PubMed Web of Science ®Google Scholar
• Miyata K, Christie RJ, Kataoka K. Polymeric micelles for nano-scale drug delivery. React Funct Polym. 2011;71:227–234.
   Web of Science ®Google Scholar
• Yokoyama M. Clinical applications of polymeric micelle carrier systems in chemotherapy and image diagnosis of solid tumors. Int J Clin Exp Med. 2011;3:151–158.
   Google Scholar
• Ma W, Guo Q, Li Y, et al. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. Eur J Pharm Biopharm. 2017;112:209–223.
   PubMed Web of Science ®Google Scholar
• Bae Y, Diezi TA, Zhao A, et al. Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents. J Control Release. 2007;122:324–330.
   PubMed Web of Science ®Google Scholar
• Cao N, Cheng D, Zou S, et al. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials. 2011;32:2222–2232.
   PubMed Web of Science ®Google Scholar
• Zhang J, Fang D, Ma Q, et al. Dual‐functional PEI–Poly (γ‐Cholesterol‐l‐Glutamate) copolymer for drug/gene co‐delivery. Macromol Chem Phys. 2014;215:163–170.
   Google Scholar
• Lee SY, Yang CY, Peng CL, et al. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy. Biomaterials. 2016;86:92–105.
   PubMed Web of Science ®Google Scholar
• Donald A, Tomalia, Mardel SA, et al. Dendrimers—an Enabling Synthetic Science to Controlled Organic Nanostructures. In: William A. Goddard Iii, Donald W, et al., editors. Handbook of Nanoscience, Engineering and Technology. Boca Raton (FL): CRC Press; 2003. p.1–34.
   Google Scholar
• Gao Y, Xie J, Chen H, et al. Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnology Advances. 2014;32:761–777.
   PubMed Web of Science ®Google Scholar
• Hu CM, Aryal S, Zhang L. Nanoparticle-assisted combination therapies for effective cancer treatment. Therapeutic Delivery. 2010;1:323–334.
   PubMedGoogle Scholar
• Grayson SM, Frechet JM. Convergent dendrons and dendrimers: from synthesis to applications. Chem Rev. 2001;101:3819–3868.
   PubMed Web of Science ®Google Scholar
• Mudshinge SR, Deore AB, Patil S, et al. Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J. 2011;19:129–141.
   PubMed Web of Science ®Google Scholar
• Svenson S, Tomalia DA. Dendrimers in biomedical applicationsreflections on the field. Adv Drug Deliv Rev. 2012;64:102–115.
   Web of Science ®Google Scholar
• Menjoge AR, Kannan RM, Tomalia DA. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today. 2010;15:171–185.
   PubMed Web of Science ®Google Scholar
• Gandhi NS, Tekade RK, Chougule MB. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. J Control Release. 2014;194:238–256.
   PubMed Web of Science ®Google Scholar
• Clementi C, Miller K, Mero A, et al. Dendritic poly (ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms. Mol Pharmaceutics. 2011;8:1063–1072.
   PubMed Web of Science ®Google Scholar
• Tekade RK, Dutta T, Gajbhiye V, et al. Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics. J Microencapsul. 2009;26:287–296.
   PubMed Web of Science ®Google Scholar
• Avgoustakis K. Pegylated poly (lactide) and poly (lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr Drug Deliv. 2004;1:321–333.
   PubMedGoogle Scholar
• Langroodi FA, Ghahestani Z, Alibolandi M, et al. Evaluation of the effect of crocetin on antitumor activity of doxorubicin encapsulated in PLGA nanoparticles. Nanomedicine. 2016;3:23–34.
   Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3:1377–1397.
   PubMed Web of Science ®Google Scholar
• Ghahestani ZH, Langroodi FA, Mokhtarzadeh A, et al. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin. Artif Cells Nanomed Biotechnol. 2017;45:955–960.
   PubMed Web of Science ®Google Scholar
• Fernandez-Fernandez A, Manchanda R, McGoron AJ. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol. 2011;165:1628–1651.
   PubMed Web of Science ®Google Scholar
• Mokhtarzadeh A, Alibakhshi A, Hejazi M, et al. Bacterial-derived biopolymers: advanced natural nanomaterials for drug delivery and tissue engineering. Trends Anal Chem. 2016;82:367–384.
   Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75:1–18.
   PubMed Web of Science ®Google Scholar
• Liu L, Won YJ, Cooke PH, et al. Pectin/poly (lactide-co-glycolide) composite matrices for biomedical applications. Biomaterials. 2004;25:3201–3210.
   PubMed Web of Science ®Google Scholar
• Hedberg EL, Shih CK, Lemoine JJ, et al. In vitro degradation of porous poly (propylene fumarate)/poly (DL-lactic-co-glycolic acid) composite scaffolds. Biomaterials. 2005;26:3215–3225.
   PubMed Web of Science ®Google Scholar
• Patil SD, Papadimitrakopoulos F, Burgess DJ. Dexamethasone-loaded poly (lactic-co-glycolic) acid microspheres/poly (vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol Ther. 2004;6:887–897.
   PubMedGoogle Scholar
• Song XR, Cai Z, Zheng Y, et al. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci. 2009;37:300–305.
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang M, Zeng F, et al. Dual-targeting magnetic PLGA nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. ACS Appl Mater Interfaces. 2016;8:32159–32169.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chui WK, Ho PC. Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapy. Pharm Res. 2011;28:585–596.
   PubMed Web of Science ®Google Scholar
• He Z, Huang J, Xu Y, et al. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. Oncotarget. 2015;6:42150.
   PubMed Web of Science ®Google Scholar
• Wang B, Yu XC, Xu SF, et al. Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma. J Nanobiotechnol. 2015;13:22.
   PubMed Web of Science ®Google Scholar
• Wu B, Lu ST, Zhang LJ, et al. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment. Int J Nanomedicine. 2017;12:1853.
   PubMed Web of Science ®Google Scholar
• Muntimadugu E, Kumar R, Saladi S, et al. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Colloids Surf B Biointerfaces. 2016;143:532–546.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang J, Wang B, et al. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles. Drug Dev Ind Pharm. 2016;42:737–746.
   PubMed Web of Science ®Google Scholar
• Şenel S, McClure SJ. Potential applications of chitosan in veterinary medicine. Adv Drug Deliv Rev. 2004;56:1467–1480.
   PubMed Web of Science ®Google Scholar
• Tripathi SK, Goyal R, Kumar P, et al. Linear polyethylenimine-graft-chitosan copolymers as efficient DNA/siRNA delivery vectors in vitro and in vivo. Nanomed Nanotechnol Biol Med. 2012;8:337–345.
   PubMed Web of Science ®Google Scholar
• Patel MP, Patel RR, Patel JK. Chitosan mediated targeted drug delivery system: a review. J Pharm Pharm Sci. 2010;13:536–557.
   PubMed Web of Science ®Google Scholar
• Alinejad V, Somi MH, Baradaran B, et al. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells. Biomed Pharmacother. 2016;83:229–240.
   PubMed Web of Science ®Google Scholar
• Wang X, Niu D, Hu C, et al. Polyethyleneimine-based nanocarriers for gene delivery. Curr Pharm Des. 2015;21:6140–6156.
   PubMed Web of Science ®Google Scholar
• Mokhtarzadeh A, Parhiz H, Hashemi M, et al. Targeted gene delivery to MCF-7 cells using peptide-conjugated polyethylenimine. AAPS PharmSciTech. 2015;16:1025–1032.
   PubMed Web of Science ®Google Scholar
• Spoden GA, Besold K, Krauter S, et al. Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection. Antimicrob Agents Chemother. 2012;56:75–82.
   PubMed Web of Science ®Google Scholar
• Yemul O, Imae T. Synthesis and characterization of poly(ethyleneimine) dendrimers. Colloid Polym Sci. 2008;286:747–752.
   Web of Science ®Google Scholar
• Creixell M, Peppas NA. Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance. Nano Today. 2012;7:367–379.
   PubMed Web of Science ®Google Scholar
• Gao S, Tian H, Guo Y, et al. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy. Acta Biomaterialia. 2015;25:184–193.
   PubMed Web of Science ®Google Scholar
• Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci U S A. 1996;93:12349–12354.
   PubMed Web of Science ®Google Scholar
• Hess GT, Humphries WHt, Fay NC, et al. Cellular binding, motion, and internalization of synthetic gene delivery polymers. Biochimica Et Biophysica Acta. 2007;1773:1583–1588.
   PubMed Web of Science ®Google Scholar
• Payne CK, Jones SA, Chen C, et al. Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands. Traffic (Copenhagen, Denmark). 2007;8:389–401.
   PubMed Web of Science ®Google Scholar
• Ruponen M, Yla-Herttuala S, Urtti A. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochimica Et Biophysica Acta. 1999;1415:331–341.
   PubMed Web of Science ®Google Scholar
• Akinc A, Thomas M, Klibanov AM, et al. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med. 2005;7:657–663.
   PubMed Web of Science ®Google Scholar
• Mokhtarzadeh A, Parhiz H, Hashemi M, et al. P53-derived peptides conjugation to PEI: an approach to producing versatile and highly efficient targeted gene delivery carriers into cancer cells. Expert Opin Drug Deliv. 2016;13:477–491.
   PubMed Web of Science ®Google Scholar
• Xu C, Tian H, Wang P, et al. The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA. Biomaterials Science. 2016;4:1646–1654.
   PubMed Web of Science ®Google Scholar
• Zhang BF, Xing L, Qiao JB, et al. In vivo synergistic antitumor effect and safety of siRNA and lonidamine dual-loaded hierarchical targeted nanoparticles. Int J Pharm. 2016;506:207–213.
   PubMedGoogle Scholar
• Ren Y, Xie H, Liu X, et al. Comparative investigation of the binding characteristics of poly-l-lysine and chitosan on alginate hydrogel. Int J Biol Macromol. 2016;84:135–141.
   PubMed Web of Science ®Google Scholar
• Lomander A, Hwang W, Zhang S. Hierarchical self-assembly of a coiled-coil peptide into fractal structure. Nano Lett. 2005;5:1255–1260.
   PubMed Web of Science ®Google Scholar
• Choi YH, Liu F, Kim JS, et al. Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier. J Control Release. 1998;54:39–48.
   PubMed Web of Science ®Google Scholar
• AlbukhatyNaderi-Manesh S, Tiraihi HT. In vitro labeling of neural stem cells with poly-l-lysine coated super paramagnetic nanoparticles for green fluorescent protein transfection. Iran Biomed J. 2013;17:71–76.
   PubMedGoogle Scholar
• Qiu B, Ji M, Song X, et al. Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer. Nanoscale Res Lett. 2012;7:1–11.
   PubMed Web of Science ®Google Scholar
• Zakerzadeh E, Alizadeh E, Kafil SH, et al. Novel antibacterial polymeric nanocomposite for smart co-delivery of anticancer drugs. Artif Cells Nanomed Biotechnol. 2016; Forthcoming. [12 p.]. doi: 10.1080/21691401.2016.1260576.
   PubMed Web of Science ®Google Scholar
• Miller K, Erez R, Segal E, et al. Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer–alendronate–taxane conjugate. Angew Chem Int Ed. 2009;48:2949–2954.
   PubMed Web of Science ®Google Scholar
• Soma C, Dubernet E, Bentolila C, et al. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials. 2000;21:1–7.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, et al. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. J Control Release. 2006;116:275–284.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li J, Shi Z, et al. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Acta Biomaterialia. 2017;58:349–364.
   PubMed Web of Science ®Google Scholar
• Guo S, Lv L, Shen Y, et al. A nanoparticulate pre-chemosensitizer for efficacious chemotherapy of multidrug resistant breast cancer. Sci Rep. 2016;6:21459.
   PubMed Web of Science ®Google Scholar
• Yao J, Zhang L, Zhou J, et al. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and paclitaxel based on hyaluronic acid-based multifunctional nanocarrier. Mol Pharmaceutics. 2013;10:1080–1091.
   PubMed Web of Science ®Google Scholar
• Zhang H, Tian Y, Zhu Z, et al. Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation. Sci Rep. 2016;6:26546.
   PubMed Web of Science ®Google Scholar
• Poon C, Duan X, Chan C, et al. Nanoscale coordination polymers codeliver carboplatin and gemcitabine for highly effective treatment of platinum-resistant ovarian cancer. Mol Pharmaceutics. 2016;13:3665–3675.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu R, Yang J, et al. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy. Biomaterials. 2014;35:9731–9745.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu X, Gao Y, et al. Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma. Int J Nanomedicine. 2016;11:3891.
   PubMed Web of Science ®Google Scholar
• Debnath B , JashimUddin B, Maiti MD. Nanoparticle (NP) as a targeting drug delivery system to blood-brain barrier (BBB): a review. PharmaTutor. 2015;3:30–37.
   Google Scholar
• Younes I, Rinaudo M. Chitin and chitosan preparation from marine sources. Structure, properties and applications. Marine Drugs. 2015;13:1133–1174.
   PubMed Web of Science ®Google Scholar
• Liu M, Ji J, Zhang X, et al. Self-polymerization of dopamine and polyethyleneimine: novel fluorescent organic nanoprobes for biological imaging applications. J Mater Chem B. 2015;3:3476–3482.
   Web of Science ®Google Scholar